R Shruthi1, R Jyothi2, H P Pundarikaksha3, G N Nagesh4, T J Tushar1. 1. Tutor, Department of Pharmacology, Kempegowda Institute of Medical Sciences , BSK-II Stage, Bangalore, Karnataka, India . 2. Associate Professor, Department of Pharmacology, Kempegowda Institute of Medical Sciences , BSK-II Stage, Bangalore, Karnataka, India . 3. Professor and Head, Department of Pharmacology, Kempegowda Institute of Medical Sciences , BSK-II Stage, Bangalore, Karnataka, India . 4. Professor, Department of Medicine, Kempegowda Institute of Medical Sciences , BSK-II Stage, Bangalore, Karnataka, India .
Abstract
INTRODUCTION: Geriatric population is more prone for various chronic and recurrent illnesses like diabetes mellitus, hypertension, IHD, arthritic, neurodegenerative, gastrointestinal, ocular, genitourinary, respiratory disorders etc., which may require chronic medication with multiple drugs. Poor compliance in this age group accounts for medication wastage with increased cost of healthcare and substantial worsening of the disease with disability or death. Most of the human and economic costs associated with non adherence can be avoided by improving medication adherence. AIM: To assess the level of medication compliance in elderly patients with chronic illnesses and to analyse the factors influencing medication compliance. MATERIALS AND METHODS: The study subjects were assessed by using twenty item structured questionnaires as per modified Morisky Medication Adherence Scale (MMAS). RESULTS: A total of 251 subjects of geriatric age group with chronic illnesses were assessed for the level of compliance for long term medications. The average number of medications 2.96±1.42 per subject and most of the subjects were receiving FDCs. The compliance level was assessed by way of interview using a twenty item structured pretested questionnaire as per modified MMAS. The level of compliance was good in 45.41%, moderate in 35.45% and poor in 19.12% of the study subjects. CONCLUSION: The level of compliance positively correlated with the educational status of the study subjects and their awareness about the diseases and prescribed medications. The overall level of compliance was higher in subjects living with spouse or families, subjects without any functional impairment, subjects who were regular for the follow-up visits and also in subjects who did not experience any adverse events.
INTRODUCTION: Geriatric population is more prone for various chronic and recurrent illnesses like diabetes mellitus, hypertension, IHD, arthritic, neurodegenerative, gastrointestinal, ocular, genitourinary, respiratory disorders etc., which may require chronic medication with multiple drugs. Poor compliance in this age group accounts for medication wastage with increased cost of healthcare and substantial worsening of the disease with disability or death. Most of the human and economic costs associated with non adherence can be avoided by improving medication adherence. AIM: To assess the level of medication compliance in elderly patients with chronic illnesses and to analyse the factors influencing medication compliance. MATERIALS AND METHODS: The study subjects were assessed by using twenty item structured questionnaires as per modified Morisky Medication Adherence Scale (MMAS). RESULTS: A total of 251 subjects of geriatric age group with chronic illnesses were assessed for the level of compliance for long term medications. The average number of medications 2.96±1.42 per subject and most of the subjects were receiving FDCs. The compliance level was assessed by way of interview using a twenty item structured pretested questionnaire as per modified MMAS. The level of compliance was good in 45.41%, moderate in 35.45% and poor in 19.12% of the study subjects. CONCLUSION: The level of compliance positively correlated with the educational status of the study subjects and their awareness about the diseases and prescribed medications. The overall level of compliance was higher in subjects living with spouse or families, subjects without any functional impairment, subjects who were regular for the follow-up visits and also in subjects who did not experience any adverse events.
Authors: Eric J MacLaughlin; Cynthia L Raehl; Angela K Treadway; Teresa L Sterling; Dennis P Zoller; Chester A Bond Journal: Drugs Aging Date: 2005 Impact factor: 3.923
Authors: F J M Spikmans; J Brug; M M B Doven; H M Kruizenga; G H Hofsteenge; M A E van Bokhorst-van der Schueren Journal: J Hum Nutr Diet Date: 2003-06 Impact factor: 3.089
Authors: Stephanie R Reading; Mary Helen Black; Daniel E Singer; Alan S Go; Margaret C Fang; Natalia Udaltsova; Teresa N Harrison; Rong X Wei; In-Lu Amy Liu; Kristi Reynolds Journal: BMC Cardiovasc Disord Date: 2019-02-11 Impact factor: 2.298
Authors: Lauren Cadel; Stephanie R Cimino; Teagan Rolf von den Baumen; Kadesha A James; Lisa McCarthy; Sara J T Guilcher Journal: Patient Prefer Adherence Date: 2021-06-16 Impact factor: 2.314